Application of high potency topical corticosteroid-containing preparations
Pruritus ani - Application of high potency topical corticosteroid-containing preparations Factor
Last reviewed for CCPS 30 June 1999.
Investigative Documents
Medical Report - Treatment with Topical Corticosteroids - Pruritus Ani [MR9178]
Preliminary questions [16841]
there is some evidence that the application of high potency topical corticosteroid-containing preparations may be a factor in the development or worsening of the condition under consideration.17011 the veteran has applied high potency topical corticosteroid-containing preparations to the perianal area at some time.
the application of high potency topical corticosteroid-containing preparations to the perianal area caused the veteran to experience steroid related atrophy of the perianal skin. the application of high potency topical corticosteroid-containing preparations to the perianal area, which caused the veteran to experience steroid related atrophy of the perianal skin, was due to an illness or injury which is identifiable.17013 — the veteran has established the causal connection between the application of high potency topical corticosteroid-containing preparations to the perianal area and VEA service for pruritus ani.
the veteran applied high potency topical corticosteroid-containing preparations to the perianal area for the identified illness or injury, and experience steroid related atrophy of the perianal skin, in the 30 days immediately before the clinical onset of the condition under consideration.17016 — the veteran has established the causal connection between the application of high potency topical corticosteroid-containing preparations to the perianal area and VEA service for the clinical onset of pruritus ani.
17018 — the veteran has established the causal connection the application of high potency topical corticosteroid-containing preparations to the perianal area and operational service for the clinical onset of pruritus ani.
or
17019 — the veteran has established the causal connection the application of high potency topical corticosteroid-containing preparations to the perianal area and eligible service for the clinical onset of pruritus ani.
or
the clinical onset of the veteran's pruritus ani occurred after the end of the veteran's last period of VEA service. the veteran's pruritus ani permanently worsened. the veteran applied high potency topical corticosteroid-containing preparations to the perianal area for the identified illness or injury, and experience steroid related atrophy of the perianal skin, in the 30 days immediately before the clinical worsening of the condition under consideration.17017 — the veteran has established the causal connection between the application of high potency topical corticosteroid-containing preparations to the perianal area and VEA service for the clinical worsening of pruritus ani.
17020 — the veteran has established the causal connection the application of high potency topical corticosteroid-containing preparations to the perianal area and operational service for the clinical worsening of pruritus ani.
or
17021 — the veteran has established the causal connection the application of high potency topical corticosteroid-containing preparations to the perianal area and eligible service for the clinical worsening of pruritus ani.
Clinical onset and operational service [17018]
17023 — the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related to operational service.
Clinical onset and eligible service [17019]
17024 — the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related to eligible service.
Clinical worsening and operational service [17020]
17023 — the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related to operational service.
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related.Clinical worsening and eligible service [17021]
17024 — the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related to eligible service.
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury for which high potency topical corticosteroid-containing preparations were applied to the perianal area, which caused steroid related atrophy of the perianal skin, is causally related.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/chronic-pruritus-ani-j014-l290/rulebase-pruritus-ani/application-high-potency-topical-corticosteroid-containing-preparations